Access Bio

Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...

South Korea’s Lotte Group is entering the bio business for the first time in its history by acquiring a significant stake in Enzychem Lifescie...

Medivate Partners, South Korea’s life science-focused private equity firm, is set to secure more than 2.5 times its investment of around 60 bi...

KB Investment Co. will join forces with US-based RM Global Partners to launch a $100 million life science fund to invest in early stage startups in ...

Samsung Electronics Co. has agreed to hand over the business rights for its in vitro diagnostics (IVD) unit to a South Korean bio company as part ...

LG Chem Ltd. plans to produce synthetic resins such as polyolefin, polycarbonate and polyvinyl chloride, using biomaterials from Finland's diesel prod...

Samsung Biologics Co. has become the world’s No. 1 contract manufacturing organization (CMO) this year and aims to also lead both the contract d...

Helixmith Co., once No.2 stock on the junior Kosdaq market, has lost 40% in the past week following its disclosure of $233 million investment in high-...

South Korea’s Celltrion Inc. and its affiliates are expected to post robust operating profits this year on the back of strong sales of Remsima a...